Predictions
Xenon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€37.60
07.09.22
07.09.22
€50.00
31.12.24
31.12.24
-6.91%
03.06.24
03.06.24
Could be very worthwhile Investment >20% year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.18
04.09.22
04.09.22
-
04.09.23
04.09.23
-9.84%
01.10.22
01.10.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
26.08.22
26.08.22
-
26.08.23
26.08.23
-4.98%
03.09.22
03.09.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.85
24.08.22
24.08.22
-
24.08.23
24.08.23
-10.03%
03.09.22
03.09.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Helius Medical Technologies Inc
Start price
Target price
Perf. (%)
€1.85
03.08.22
03.08.22
-
03.08.23
03.08.23
-92.76%
14.05.23
14.05.23
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.16
24.07.22
24.07.22
-
24.07.23
24.07.23
-2.64%
04.09.22
04.09.22
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.37
21.07.22
21.07.22
€5.30
21.07.23
21.07.23
-21.42%
11.03.23
11.03.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.09
10.07.22
10.07.22
-
10.07.23
10.07.23
1.76%
23.07.22
23.07.22
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€8.93
09.07.22
09.07.22
€4.00
09.07.23
09.07.23
-40.65%
23.07.22
23.07.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.81
04.07.22
04.07.22
-
04.07.23
04.07.23
-24.63%
06.08.22
06.08.22
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.27
27.06.22
27.06.22
-
27.06.23
27.06.23
-4.35%
09.07.22
09.07.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.23
28.05.22
28.05.22
-
28.05.23
28.05.23
-9.57%
11.06.22
11.06.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.23
28.05.22
28.05.22
-
28.05.23
28.05.23
-56.27%
24.04.23
24.04.23
Probably not worthwhile Investment
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.89
14.05.22
14.05.22
-
14.05.23
14.05.23
-13.51%
28.05.22
28.05.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.45
30.04.22
30.04.22
-
30.04.23
30.04.23
-10.35%
14.05.22
14.05.22
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.37
28.04.22
28.04.22
€2.00
28.04.23
28.04.23
0.74%
03.08.22
03.08.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€5.99
19.04.22
19.04.22
-
12.04.24
12.04.24
-68.19%
12.04.24
12.04.24
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€7.00
25.03.22
25.03.22
-
25.03.23
25.03.23
-11.25%
02.04.22
02.04.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.15
21.03.22
21.03.22
€4.00
21.03.23
21.03.23
11.30%
04.04.22
04.04.22
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€1.15
19.03.22
19.03.22
€0.000
19.03.23
19.03.23
11.30%
02.04.22
02.04.22
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.96
07.03.22
07.03.22
-
07.03.23
07.03.23
27.52%
28.03.22
28.03.22
Could be worthwhile Investment >10% per year
Organigram Holdings Inc.
Start price
Target price
Perf. (%)
€4.96
06.03.22
06.03.22
-
06.03.23
06.03.23
9.97%
30.04.22
30.04.22
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.94
06.03.22
06.03.22
-
06.03.23
06.03.23
-0.02%
30.04.22
30.04.22
Risky Investment
Aurinia Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.27
20.02.22
20.02.22
-
20.02.23
20.02.23
-34.89%
05.03.22
05.03.22